company background image
SILVAPHL logo

Silva Pharmaceuticals DSE:SILVAPHL Stock Report

Last Price

৳16.00

Market Cap

৳2.2b

7D

-2.4%

1Y

-25.9%

Updated

26 Mar, 2024

Data

Company Financials

Silva Pharmaceuticals Limited

DSE:SILVAPHL Stock Report

Market Cap: ৳2.2b

SILVAPHL Stock Overview

Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh.

SILVAPHL fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Silva Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Silva Pharmaceuticals
Historical stock prices
Current Share Price৳16.00
52 Week High৳21.60
52 Week Low৳15.80
Beta0.040
1 Month Change-11.60%
3 Month Change-25.93%
1 Year Change-25.93%
3 Year Change-12.57%
5 Year Change-35.63%
Change since IPO-42.07%

Recent News & Updates

Recent updates

Shareholder Returns

SILVAPHLBD PharmaceuticalsBD Market
7D-2.4%-1.8%-1.6%
1Y-25.9%-12.7%-13.5%

Return vs Industry: SILVAPHL underperformed the BD Pharmaceuticals industry which returned -12.7% over the past year.

Return vs Market: SILVAPHL underperformed the BD Market which returned -13.5% over the past year.

Price Volatility

Is SILVAPHL's price volatile compared to industry and market?
SILVAPHL volatility
SILVAPHL Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement5.7%
10% most volatile stocks in BD Market8.8%
10% least volatile stocks in BD Market3.2%

Stable Share Price: SILVAPHL's share price has been volatile over the past 3 months.

Volatility Over Time: SILVAPHL's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001594Saira Khanhttps://www.silvapharma.com

Silva Pharmaceuticals Limited engages in manufacture and marketing of pharmaceutical products in Bangladesh. The company offers drugs for antibiotics, antifungals, analgesics, anti-diabetics, anti-pyretics, anti-inflammatory, anti-ulcerants, respiratory, cardiovascular, central nervous system, dermatology, gastrointenstinal, antiemetic and anti-spasmodic, antibacterial, allergies, cough, and cold, as well as natural sweetner, vitamins and minerals. It also provides medicine and vaccine for farmers and fisheries; agricultural chemicals and public health insecticides; and herbal and neutraceutical products.

Silva Pharmaceuticals Limited Fundamentals Summary

How do Silva Pharmaceuticals's earnings and revenue compare to its market cap?
SILVAPHL fundamental statistics
Market cap৳2.18b
Earnings (TTM)-৳28.15m
Revenue (TTM)৳637.53m

3.4x

P/S Ratio

-77.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SILVAPHL income statement (TTM)
Revenue৳637.53m
Cost of Revenue৳464.41m
Gross Profit৳173.13m
Other Expenses৳201.28m
Earnings-৳28.15m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.21
Gross Margin27.16%
Net Profit Margin-4.42%
Debt/Equity Ratio1.9%

How did SILVAPHL perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

-48%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.